User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions

Pancreatic cancer and cannabis + 'GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine', a 2018 study published in Oncogene. Forbes.com news item on the study 'Study: CBD From Marijuana Plus Chemotherapy Tripled Cancer Survival Rates In Mice'
imported>Jukeboksi
(→‎Lung cancer and cannabis: + 'Striking lung cancer response to self-administration of cannabidiol: A case report and literature review')
imported>Jukeboksi
(Pancreatic cancer and cannabis + 'GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine', a 2018 study published in Oncogene. Forbes.com news item on the study 'Study: CBD From Marijuana Plus Chemotherapy Tripled Cancer Survival Rates In Mice')
Line 588: Line 588:


* [https://www.independent.co.uk/news/health/pancreatic-cancer-medical-cannabis-cbd-oil-cannabidiol-chemotherapy-a8470406.html Medical cannabis extract could help pancreatic cancer patients live longer, early study suggests] an 2019 article in the Independent
* [https://www.independent.co.uk/news/health/pancreatic-cancer-medical-cannabis-cbd-oil-cannabidiol-chemotherapy-a8470406.html Medical cannabis extract could help pancreatic cancer patients live longer, early study suggests] an 2019 article in the Independent
''' Studies about pancreatic cancer and cannabis '''
* [https://www.nature.com/articles/s41388-018-0390-1 'GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine'], a 2018 study published in [[w:Oncogene (journal)|Oncogene]]. Forbes.com news item on the study [https://www.forbes.com/sites/daviddisalvo/2018/07/31/study-cbd-from-marijuana-plus-chemotherapy-triples-cancer-survival-rates-in-mice/ 'Study: CBD From Marijuana Plus Chemotherapy Tripled Cancer Survival Rates In Mice']


----
----
Anonymous user